Gibson Dunn Guides Gene Test Co.'s IPO Amid COVID Slump
Genetic testing company Progenity filed a preliminary initial public offering of $100 million and said profits from the offering will likely be used to fund research and development of its products....To view the full article, register now.
Already a subscriber? Click here to view full article